1446418-48-9
1446418-48-9
Chemical Structure
Abacavir hydroxyacetate
- CAS. Nr.: 1446418-48-9
- Formula:C16H20N6O3
- Molecular Weight:344.37
IUPAC Name: ((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl 2-hydroxyacetate
InChIKey: ZBBZROWQLKCFQK-KOLCDFICSA-N
SMILES: OCC(OC[C@H](C=C1)C[C@H]1N2C3=NC(N)=NC(NC4CC4)=C3N=C2)=O
Biological Activity: Abacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of skin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory skin problems[1][2].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Abacavir hydroxyacetate | 99.61% | Abacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of skin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory skin problems. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Abacavir hydroxyacetate (Standard) | Abacavir hydroxyacetate (Standard) is the analytical standard of Abacavir hydroxyacetate (HY-106647). This product is intended for research and analytical applications. Abacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of sKin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory sKin problems. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Guda A, et al. Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon. Expert Opin Investig Drugs. 2018 Nov;27(11):931-939. [Content Brief]
- [2]. Menon, et al. CARBOCYCLIC NUCLEOSIDES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS. WO/2013/103601/Al.
